Gene editing of angiotensin for blood pressure management
Arterial hypertension has remained the world's leading cause of morbidity and mortality for more than 20 years. While early Genome-Wide Association Studies raised the hypothesis that a precision medicine approach could be implemented in the treatment of hypertension, the large number of single...
Saved in:
| Main Authors: | Stefano Masi, Hermann Dalpiaz, Claudio Borghi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | International Journal of Cardiology. Cardiovascular Risk and Prevention |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772487524000886 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of the <i>M235T</i> polymorphism of the angiotensinogen gene on the office blood pressure during therapy with angiotensin II receptor blockers
by: E. V. Rebrova, et al.
Published: (2024-12-01) -
Impact of Daily Berry Supplementation on Blood Pressure and Intestinal Health in Angiotensin II-Treated Rats
by: Jessica P Danh, et al.
Published: (2025-05-01) -
Renal Inhibition of Heme Oxygenase-1 Increases Blood Pressure in Angiotensin II-Dependent Hypertension
by: Eva Csongradi, et al.
Published: (2012-01-01) -
The Brain Renin-Angiotensin System and Mitochondrial Function: Influence on Blood Pressure and Baroreflex in Transgenic Rat Strains
by: Manisha Nautiyal, et al.
Published: (2013-01-01) -
Alantolactone mitigates the elevation of blood pressure in mice induced by angiotensin II by inhibiting calcium channel activation
by: Ruqiang Yuan, et al.
Published: (2025-01-01)